Mission Therapeutics is down to its clinical assets MTX652 and MTX325, which work by disabling a key enzyme that interferes ...

A study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day ...

Derm-Biome Pharmaceuticals Inc. has reported findings from a study of its topical drug DB-007-5 in a well-established ...

Seismic Therapeutic, Inc., the machine learning immunology company, today announced the presentation of preclinical data for ...

Mutations in the TP53 gene occur in approximately half of human cancer types, with the TP53 Y220C mutation found in 1% of all solid tumors. Researchers from PMV Pharmaceuticals Inc. and collaborators ...

Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) ...

Equities researchers at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued on Friday. The brokerage set a “sell” rating ...

Inventiva (IVA) announced the publication in Biomedicine & Pharmacotherapy, a peer-reviewed, scientific journal, of the results from a ...